Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

axios.com - Adriel Bettelheim - Pharma's next cash cows could be specialized treatments
Pharma's next cash cows could be specialized treatments
Axios –

Pharmaceutical companies facing a steep patent cliff are concluding the key to future profits may be customized treatments tailored to patients' genes and lifestyles — not blockbusters aimed at large patient populations. Why it matters: The…

fool.com - James Halley - Should You Invest $1,000 in BridgeBio Pharma Right Now?
Should You Invest $1,000 in BridgeBio Pharma Right Now?
The Motley Fool –

BridgeBio Pharma (BBIO +5.97%) is a biotech on the verge of a breakout. The company focuses on rare genetic diseases. It has only two approved therapies right now: Attruby and Nulibry. Attruby is the company's main earner right now. The drug treats…

econotimes.com - Helena Ward - Sun Pharma Posts 11.9% Revenue Growth as Organon Deal Awaits Reviews
Sun Pharma Posts 11.9% Revenue Growth as Organon Deal Awaits Reviews
EconoTimes –

Sun Pharmaceutical Industries Limited reported 11.9% year-over-year revenue growth for the quarter ended Sept. 30, while its proposed $11.75 billion acquisition of Organon remained subject to regulatory approvals. Revenue from operations totaled…

thehindubusinessline.com - BL Mumbai Bureau - Sun Pharma slides nearly 2% as Ilumya concerns weigh on analyst estimates
Sun Pharma slides nearly 2% as Ilumya concerns weigh on analyst estimates
The HinduBusinessLine –

Updated - November 02, 2026 at 02:06 PM. Shares of Sun Pharmaceutical Industries fell sharply on Monday, declining 1.81 per cent to ₹1,745.60 on the NSE by early afternoon, with the stock touching a session low of ₹1,722. The selloff…

rediff.com - Nandita Malik - Indian Stock Market Jumps: Sensex Rallies on Reliance Earnings, Lower Crude Prices
Indian Stock Market Jumps: Sensex Rallies on Reliance Earnings, Lower Crude Prices
Rediff.com –

Indian stock markets witnessed a robust rally in early trade, with the Sensex jumping over 760 points, propelled by a strong performance from bellwether Reliance Industries following its impressive quarterly earnings and a significant drop in…

fool.com - Keith Speights - Prediction: AbbVie's Next Blockbuster Is Hiding in a Two-Drug Crohn's Combo
Prediction: AbbVie's Next Blockbuster Is Hiding in a Two-Drug Crohn's Combo
The Motley Fool –

AbbVie (ABBV +1.41%) has already pulled off one of the great commercial pivot stories in pharmaceutical history. When Humira -- once pharma's top-selling drug -- lost patent exclusivity, the Chicago-based company leaned on Skyrizi and Rinvoq, which…

thehindubusinessline.com - BL Chennai Bureau - IIT Madras' DMST to Host 'Partnering for Life' Pharmaceutical Industry Meet on December 1
IIT Madras' DMST to Host 'Partnering for Life' Pharmaceutical Industry Meet on December 1
The HinduBusinessLine –

Updated - November 02, 2026 at 03:44 PM. The Department of Medical Sciences and Technology at the IIT Madras is inviting pharma and biotechnology leaders and stakeholders for a Pharmaceutical Industry Meet titled “Partnering for Life”…

indianexpress.com - Express Web Desk - India News Live Updates, 2 November 2026: Sensex jumps over 1,000 points; Reliance Industries shares surge by over 6%
India News Live Updates, 2 November 2026: Sensex jumps over 1,000 points; Reliance Industries shares surge by over 6%
The Indian Express –

Benchmark indices Sensex and Nifty surged in early trade on Monday, tracking a sharp rally in Reliance Industries after its quarterly earnings, lower crude oil prices, foreign fund inflows and gains in Asian markets. While the Sensex opened at a…

seekingalpha.com - Albert Anthony - Iron Mountain: The Data-Focused REIT Looking To Climb Ahead After Q3 Results (NYSE:IRM)
Iron Mountain: The Data-Focused REIT Looking To Climb Ahead After Q3 Results (NYSE:IRM)
Seeking Alpha –

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

rediff.com - Nandita Malik - Sensex jumps 1,233 points as Reliance surges, crude oil prices fall
Sensex jumps 1,233 points as Reliance surges, crude oil prices fall
Rediff.com –

Indian benchmark indices, Sensex and Nifty, witnessed a significant rally, with the Sensex jumping 1,233 points, propelled by a strong performance from Reliance Industries post-earnings and a steep fall in global crude oil prices. The BSE Sensex…

express.co.uk - Ethan Davies - Blood pressure drug urgently recalled over safety concerns
Blood pressure drug urgently recalled over safety concerns
Daily Express –

File photo of someone taking a pill Regulators have issued a recall for more than 3,000 bottles of blood pressure medication after it failed safety tests. The three-in-one pill, which contains olmesartan, amlodipine, and hydrochlorothiazide to…

econotimes.com - Celia Rowan - Raja Venkatraman Sets Conditional Trading Levels for Three Indian Stocks
Raja Venkatraman Sets Conditional Trading Levels for Three Indian Stocks
EconoTimes –

Three Indian stocks have conditional trading setups for Nov. 2 from NeoTrader co-founder Raja Venkatraman, whose calls published by LiveMint specify entry triggers, stop-losses and targets. The column sets entry triggers at ₹1,760 for Ather…

cyclingnews.com - Owen Rogers - EF Education-EasyPost's head sports director Charly Wegelius departs after 15 years with the team
EF Education-EasyPost's head sports director Charly Wegelius departs after 15 years with the team
Cyclingnews –

After spending a huge 15 seasons with EF Education-EasyPost, the team's Head Sports Director Charly Wegelius will leave the outfit at the end of the year. Wegelius joined what was then known as Garmin Sharp in 2012, after an 11-year stint as a pro…

thehindubusinessline.com - Anupama Ghosh - Markets open higher as AI selloff boosts anti-tech trade; Reliance, Tata Steel lead gains
Markets open higher as AI selloff boosts anti-tech trade; Reliance, Tata Steel lead gains
The HinduBusinessLine –

Reliance Industries led the Nifty50 gainers, rising 4.59 per cent to ₹1,218.40 from a previous close of ₹1,164.90. Tata Steel followed with a gain of 3.88 per cent to ₹174.10, while state-owned power utility NTPC added 2.96 per…

econotimes.com - Celia Rowan - Nifty 50 Ends Week 2% Higher as Choice Broking Sets 23,200 Hurdle
Nifty 50 Ends Week 2% Higher as Choice Broking Sets 23,200 Hurdle
EconoTimes –

India's Nifty 50 rose 2% in the week ended Oct. 30, as Choice Broking Ltd. identified 23,200 as the index's next resistance level and set a higher range conditional on a break through it. The benchmark closed Friday at 23,053.10, gaining 116.35…

Receive a Daily briefing on Pharma Industry News

Get Started